➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Progesterone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for progesterone and what is the scope of patent protection?

Progesterone is the generic ingredient in six branded drugs marketed by Amneal Pharms Ny, Bionpharma Inc, Dr Reddys, Eugia Pharma, Sofgen Pharms, Teva Pharms, Xiromed, Virtus Pharms, Allergan, Actavis Labs Ut Inc, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, Lilly, Alza, Ferring, and Ferring Pharms Inc, and is included in eighteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Progesterone has fifty-three patent family members in twenty-five countries.

There are fifty-seven drug master file entries for progesterone. Twenty-one suppliers are listed for this compound.

Summary for progesterone

International Patents:	53
US Patents:	3
Tradenames:	6
Applicants:	17
NDAs:	18
Drug Master File Entries:	57
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	100
Clinical Trials:	992
Patent Applications:	6,615
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for progesterone
Drug Sales Revenues:	Drug sales revenues for progesterone
What excipients (inactive ingredients) are in progesterone?	progesterone excipients list
DailyMed Link:	progesterone at DailyMed

See drug prices for progesterone

Drug Sales Revenue Trends for progesterone

See drug sales revenues for progesterone

Recent Clinical Trials for progesterone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Anqin Zhang	Phase 2
Vedic Lifesciences Pvt. Ltd.	Phase 4
rana alaaeldin aly ibrahim nasr	Phase 1/Phase 2

See all progesterone clinical trials

Pharmacology for progesterone

Drug Class	Progesterone

Medical Subject Heading (MeSH) Categories for progesterone

Progestins

US Patents and Regulatory Information for progesterone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bionpharma Inc	PROGESTERONE	progesterone	CAPSULE;ORAL	200900-001	Aug 16, 2013	AB	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Am Regent	PROGESTERONE	progesterone	INJECTABLE;INJECTION	090845-001	Jun 22, 2009		DISCN	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Xiromed	PROGESTERONE	progesterone	CAPSULE;ORAL	205229-001	Oct 20, 2017	AB	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Eugia Pharma	PROGESTERONE	progesterone	INJECTABLE;INJECTION	210965-001	Dec 6, 2018	AO	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for progesterone

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	CRINONE	progesterone	GEL;VAGINAL	020701-001	Jul 31, 1997	⤷ Try it Free	⤷ Try it Free
Ferring	ENDOMETRIN	progesterone	INSERT;VAGINAL	022057-001	Jun 21, 2007	⤷ Try it Free	⤷ Try it Free
Ferring	ENDOMETRIN	progesterone	INSERT;VAGINAL	022057-001	Jun 21, 2007	⤷ Try it Free	⤷ Try it Free
Allergan	CRINONE	progesterone	GEL;VAGINAL	020701-002	Jul 31, 1997	⤷ Try it Free	⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for progesterone

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
New Zealand	596844	⤷ Try it Free
Japan	5507467	⤷ Try it Free
South Korea	101730517	⤷ Try it Free
Japan	2011510984	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for progesterone

Subscribe to access the full database, or Try it Free
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0113964	97C0037	Belgium	⤷ Try it Free	PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.